A leading private equity player

The power of and

Companies must face multiple challenges to innovate, grow and adapt to a rapidly changing environment. It has been Andera Partners’ mission for over 20 years to help companies and their management achieve strong and sustainable growth. Our conviction, at the heart of our commitment, our partnership and our way to work with entrepreneurs, is that to grow and develop, it is essential to have the right partners and enjoy working together. The Power of And thus becomes Andera Partners’ signature that relays our conviction.

Our commitments Our investments

4 billion under management

300 companies supported in over 20 years

110 professionals

Our Activities

Andera Partners is an asset management firm specialising in Private Equity. We draw on our expertise in various areas to provide a range of well-defined investment strategies. Our goal is to provide bespoke solutions to meet the challenges faced by leaders and their development models.

Our activities

Our Latest News

Below you will find all the latest news on Andera Partners, its teams and its investments.

18.09.2023 - andera MidCap - Press releases

Andera Partners increases the hard cap for Andera MidCap 5 and raises a final amount of €750 million

Combined Shape

24.07.2023 - andera Life Sciences - Press releases

Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumo…

Combined Shape

11.07.2023 - Andera Partners - Sustainability - Publications

2022 Sustainability Report

Combined Shape

06.07.2023 - andera MidCap - Press releases

PAI Partners to acquire majority stake in Infra Group

Combined Shape

04.07.2023 - andera Expansion/Croissance - Press releases

ELAN Languages completes acquisition of German group Lingua-World GmbH

Combined Shape

27.06.2023 - andera Life Sciences - Press releases

Allecra Therapeutics Submits New Drug Application to the U.S. FDA for EXBLIFEP® for the Treatment of…

Combined Shape

14.06.2023 - andera MidCap - Press releases

Andera Partners and Pauwels Consulting management team join forces to accelerate the development of…

Combined Shape

01.06.2023 - andera Life Sciences - Press releases

Inotrem announces publication of two key articles on nangibotide Phase II programs in peer-reviewed…

Combined Shape

15.05.2023 - andera Life Sciences - Press releases

Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg t…

Combined Shape

10.05.2023 - Andera Partners - Press releases

Andera Partners appoints Stefan Keitel Senior Advisor DACH region further strengthening its presence…

Combined Shape

20.04.2023 - andera Life Sciences - Press releases

Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation A…

Combined Shape

18.04.2023 - andera Life Sciences - Press releases

Andera Partners co-leads a Series A extension round of € 47.75 million for radiopharmaceutical compa…

Combined Shape

13.04.2023 - andera Life Sciences - Press releases

Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix®

Combined Shape

29.03.2023 - andera Life Sciences - Press releases

Grey Wolf Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of GRWD5769 in…

Combined Shape

15.03.2023 - andera Life Sciences - Press releases

Andera Partners co-leads $25m extension round for FIRE1

Combined Shape
Our Latest News